Durvalumab vs Insulin Glargine

## Durvalumab vs Insulin Glargine: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Insulin Glargine**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Insulin Glargine — 12-24 hours.

## Chemical Properties

**Type**: Durvalumab — Antibody; Insulin Glargine — Protein.